Multiple myeloma is a rare but serious cancer that affects plasma cells in a dog’s bone marrow. While it accounts for only a small percentage of canine cancers, its effects on the bones, kidneys, and immune system can be wide-ranging. Early symptoms such as lethargy, bone pain, and unexplained bleeding often go unnoticed until the disease has progressed. Understanding the warning signs and seeking prompt veterinary diagnosis can make a meaningful difference in your dog’s quality of life and long-term outlook.
What is Multiple Myeloma in Dogs?
Multiple myeloma is a type of cancer that originates from plasma cells, specialized white blood cells found in the bone marrow that are responsible for producing antibodies. In dogs with this condition, a single abnormal plasma cell undergoes malignant transformation and multiplies uncontrollably, crowding out healthy marrow cells and disrupting normal blood production.
These cancerous plasma cells produce excessive quantities of a non-functional antibody protein, known as a paraprotein or M-protein, which accumulates in the blood and urine. Over time, this buildup can cause widespread systemic damage. The abnormal protein deposits can impair kidney function, thicken the blood (a condition called hyperviscosity), and suppress the immune system’s ability to fight infection.
Canine multiple myeloma also directly damages bone tissue. The proliferating plasma cells secrete substances that activate bone-destroying cells (osteoclasts), leading to lytic bone lesions, areas of weakened or destroyed bone visible on X-rays. These lesions can cause fractures, chronic pain, and, in some cases, neurological complications if they occur near the spine.
Symptoms of Multiple Myeloma in Dogs
The clinical signs of multiple myeloma in dogs are often vague and nonspecific in the early stages, which makes the disease challenging to identify without veterinary testing. Because the cancer affects multiple organ systems simultaneously, including the skeletal system, kidneys, blood, and nervous system, the symptoms can vary considerably from one dog to another depending on which areas are most affected.
Some dogs may present primarily with bone-related complaints, while others show signs of kidney disease, neurological changes, or bleeding disorders. This variability means that owners and veterinarians alike must remain alert to a broad range of potential warning signs.
Common Clinical Signs
• Bone pain and lameness: Lytic lesions weaken bones and cause chronic pain, leading to reluctance to move or noticeable limping.
• Lethargy and weakness: Anemia caused by bone marrow crowding reduces red blood cell production, leaving dogs tired and lacking energy.
• Weight loss and reduced appetite: Systemic illness and metabolic disruption commonly reduce a dog’s interest in food.
• Abnormal bleeding or bruising: Low platelet counts and impaired clotting function can lead to nosebleeds, bruising, or prolonged bleeding from minor injuries.
• Increased thirst and urination: Kidney damage from M-protein deposits and high blood calcium levels causes dogs to drink and urinate excessively.
• Vision problems: Hyperviscosity syndrome, thickening of the blood can affect blood flow to the retina and cause visual disturbances.
• Frequent infections: The immune system is compromised by reduced production of healthy antibodies, making dogs more susceptible to bacterial infections.
• Neurological symptoms: Spinal lesions or nerve compression can result in hind limb weakness, coordination problems, or, in severe cases, paralysis.
Causes and Risk Factors
The exact cause of multiple myeloma in dogs is not fully understood. As with many cancers, it is likely the result of a complex interaction between genetic and environmental factors rather than a single identifiable trigger.
Genetic predisposition is believed to play a role, as certain breeds appear to be diagnosed more frequently than others. German Shepherds are among the breeds most commonly reported in studies of canine multiple myeloma. Age is also a significant risk factor; the disease is rare in young dogs and most commonly diagnosed in middle-aged to older animals, typically between 8 and 12 years of age.
Chronic immune system dysfunction may contribute to the development of malignant plasma cell tumors over time. Some researchers have explored possible links to prolonged antigen stimulation or immune dysregulation, though no definitive causal relationship has been established. Environmental exposures such as prolonged contact with certain chemicals or toxins are also considered possible contributing factors, although evidence in dogs remains limited.
How Veterinarians Diagnose Multiple Myeloma
Diagnosing multiple myeloma in dogs is rarely a straightforward process. Because the symptoms overlap with many other conditions, veterinarians must rely on a combination of laboratory tests, imaging, and sometimes tissue sampling to confirm the diagnosis.
The diagnostic criteria for canine multiple myeloma typically require the presence of at least two of four key findings: abnormal plasma cell proliferation in the bone marrow, a detectable M-protein spike in the blood or urine, lytic bone lesions on X-rays, and elevated levels of Bence-Jones proteins in the urine. Meeting two or more of these criteria, combined with consistent clinical signs, generally supports a diagnosis.
Your veterinarian may refer your dog to a veterinary internal medicine specialist or oncologist if multiple myeloma is suspected, as the workup involves several specialized tests that benefit from expert interpretation.
Diagnostic Tests Used
• Complete blood count (CBC) and serum chemistry panel: These routine blood tests identify anemia, low platelet counts, abnormal white blood cell levels, elevated calcium (hypercalcemia), and signs of kidney or liver involvement.
• Serum protein electrophoresis (SPEP): This specialized blood test detects and measures abnormal immunoglobulin proteins (M-proteins) produced by cancerous plasma cells, a hallmark of multiple myeloma.
• Urinalysis and urine protein electrophoresis: Urine is tested for Bence-Jones proteins, which are small antibody fragments produced by myeloma cells that pass through the kidneys and appear in the urine.
• Skeletal radiographs (X-rays): Full-body X-rays are taken to identify characteristic lytic bone lesions, punched-out areas of bone destruction, that are a classic sign of multiple myeloma.
• Bone marrow biopsy or aspirate: A sample of bone marrow is collected and examined microscopically to look for excessive plasma cell infiltration, which confirms the diagnosis.
Treatment Options for Multiple Myeloma in Dogs
While multiple myeloma in dogs is not considered curable, it is one of the more treatable cancers in veterinary oncology. The primary goal of treatment is to reduce the cancer cell burden, relieve symptoms, preserve organ function, and maintain a good quality of life for as long as possible.
Chemotherapy is the cornerstone of treatment for canine multiple myeloma, and many dogs respond well, sometimes dramatically, to oral chemotherapy protocols. Unlike in humans, chemotherapy in dogs is generally administered at lower doses designed to minimize side effects while still controlling tumor growth. Most dogs tolerate treatment well and maintain a good quality of life during therapy.
In addition to chemotherapy, supportive care plays a critical role in managing the complications of multiple myeloma. Dogs are typically monitored with regular blood and urine tests throughout treatment to assess response, detect relapse early, and adjust therapy as needed.
Common Treatment Methods
• Chemotherapy (melphalan and prednisone): The standard first-line treatment involves oral melphalan combined with prednisone. This combination reduces plasma cell proliferation and M-protein levels, with many dogs achieving partial or complete remission.
• Radiation therapy: For dogs with painful localized bone lesions or spinal involvement, targeted radiation can reduce pain, shrink lesions, and improve mobility.
• Pain management: NSAIDs, opioids, or other analgesics are prescribed to manage bone pain and improve comfort throughout treatment.
• Antibiotics and infection prevention: Because the immune system is compromised, dogs may require antibiotics to manage bacterial infections that arise during treatment.
• Fluid therapy and kidney support: Intravenous or subcutaneous fluids help flush excess proteins and calcium from the kidneys and support overall kidney function.
Prognosis for Dogs with Multiple Myeloma
The prognosis for dogs with multiple myeloma is more favorable than many owners expect. When treated with chemotherapy, studies report that approximately 90% of dogs achieve at least a partial response, with median survival times ranging from 18 months to over 3 years in some cases. Many dogs enjoy a good quality of life for an extended period following diagnosis.
Dogs that are not treated, or in which the disease is diagnosed at a very advanced stage, have a significantly shorter prognosis, often measured in weeks to a few months. This underscores the importance of early detection and prompt initiation of therapy.
Factors that influence prognosis include the degree of kidney involvement at diagnosis, the severity of hypercalcemia, the extent of bone lesions, and how well the dog responds to initial treatment. Dogs that achieve remission and are monitored closely for relapse generally fare best.
When to See a Veterinarian
If your dog is showing any persistent or unexplained symptoms, including bone pain, lameness, unusual fatigue, excessive drinking and urination, unexplained bleeding, or recurring infections, it is important to seek veterinary attention promptly. While these signs do not necessarily indicate multiple myeloma, they warrant a thorough clinical evaluation to identify the underlying cause.
Early diagnosis is one of the most significant factors in determining treatment success. Dogs diagnosed before severe organ damage has occurred tend to respond better to chemotherapy and enjoy a longer period of disease control. Don’t wait for symptoms to worsen; a simple blood panel can often provide the first clues that something is wrong.
Preventing Cancer in Dogs: Is It Possible?
Complete prevention of multiple myeloma or most cancers in dogs is not currently possible. The disease involves complex genetic and biological factors that cannot be fully controlled through lifestyle or environmental changes alone.
However, scheduling routine veterinary wellness exams at least once or twice a year for older dogs allows for early identification of abnormal findings. Feeding a balanced, high-quality diet, maintaining a healthy body weight, limiting unnecessary chemical exposures, and keeping up with vaccinations and parasite prevention all contribute to a stronger immune system and general wellbeing.
Final Thoughts
Multiple myeloma is a rare but manageable cancer in dogs. With the right diagnosis and a tailored treatment plan, many dogs go on to live comfortable, meaningful lives long after their initial diagnosis. Early detection remains the single most important factor in achieving the best possible outcome, so if your dog is showing any unusual or persistent symptoms, don’t hesitate to consult your veterinarian. Staying proactive about your dog’s health, attending regular check-ups, and knowing the warning signs can make all the difference.
Related Videos
